Waystar Considers Sale Amid Falling Market Value, Sources Say

Waystar, a prominent healthcare software provider, is reportedly considering a sale, according to sources familiar with the situation. The company, known for its technology that automates administrative tasks for hospitals and doctors, has engaged investment bank Evercore to explore its options. This move comes two years after Waystar's public listing in New York.

Based in Lehi, Utah, and Louisville, Kentucky, Waystar has seen its market value drop to approximately $4.8 billion following a 24% decline in share price this year. This downturn aligns with a broader selloff in the software sector. The potential sale could test the market's appetite for software companies at a time when investor confidence in the sector is wavering.

Exploring Strategic Alternatives

The exploration of a sale is still in its early stages, and sources caution that plans may change. Waystar's approach to positioning itself as a technology company, rather than a service-based business, aimed to capitalize on the higher valuations typically associated with tech firms. Initially, this strategy was successful, with shares peaking at $45 in 2025, up from $20 at the time of the IPO.

However, concerns over the impact of artificial intelligence advancements on software companies have put pressure on Waystar's stock, as noted by Morgan Stanley analysts in a July report.

Ownership and Financial Backing

Waystar was formed through the 2017 merger of Zirmed and Navicure, two healthcare revenue management firms. The company's major shareholders include EQT, the Canada Pension Plan Investment Board (CPPIB), and Bain Capital. EQT remains the largest shareholder with a 13% stake, followed by CPPIB with 10%, and BlackRock Institutional Trust Company holding 8%, according to data from LSEG.

Despite the current financial challenges, Waystar's strategic positioning as a healthcare software provider could still appeal to potential buyers. The company's technology solutions are integral to streamlining payment processes for healthcare providers, offering efficiency gains that are increasingly valuable in the sector.

Market Conditions and Future Prospects

The potential sale of Waystar comes at a time when the software industry is facing significant headwinds. As the market reassesses the value of software firms amid technological advances and economic fluctuations, Waystar's decision to explore strategic alternatives could be seen as a proactive measure to adapt to changing conditions. Whether the sale proceeds will likely depend on the interest and valuations offered by potential buyers.

As the situation develops, stakeholders in the healthcare and software industries will be closely monitoring Waystar's next moves, given its significant role in healthcare administration technology.